A randomized double-blind study was conducted in 83 
EMLA cream (Eutectic mixture, lignocaine/prilocaine 5%, Astra Pharmaceuticals, Australia) has found several applications for dermal analgesia in adult medicine. In the awake patient about to undergo a major surgical procedure, attempts to minimize the discomfort of epidural insertion may make an important contribution to reduction of anxiety and greater patient satisfaction.
It has been suggested that analgesia provided by EM LA reaches a depth of 5-6 mml,2. The application of EMLA to the skin of the back results in more rapid analgesia than at other skin sites 3 • However, a recent study using an application time of ten minutes prior to epidural analgesia for women in labour found higher pain scores with greater variability, compared with lignocaine infiltration'.
For planned procedures early administration of EMLA is feasible, and it was our clinical impression that in the setting of elective caesarean section, EM LA reduced patient discomfort during epidural insertion.
The aim of this randomized, double-blind study was to evaluate the efficacy of EMLA and lignocaine infiltration prior to epidural insertion for elective caesarean section.
MATERIALS AND METHODS
Following Institutional Research and Ethics Committee approval, written informed consent was obtained from 83 women scheduled for elective caesarean section.
Ward application of EMLA or placebo cream 2.5g was made at least 90 minutes prior to anaesthesia. The tubes were prepared by the hospital pharmacy and contained either EMLA or an aqueous cream with added paraffin of similar appearance. The entire contents of the coded tube was thickly applied over two lumbar interspaces (as marked by the anaesthetist on the preoperative visit) and covered with an occlusive dressing (lOx14 cm Opsite, Smith & Nephew).
In the operating theatre, the occlusive dressing and any remaining cream was removed. Skin colour and general appearances were noted prior to sterile skin preparation. Intradermal infiltration was performed with a 26-gauge needle followed by subdermal infiltration with a 23-gauge needle, using up to 3 ml of solution. The anaesthetist, attending nurse and patient were blind to the identity of the solution.
Patients were randomly allocated to one of three groups; Group A (EM/LJG) received EMLA and 1070 lignocaine, Group B (EM/SAL) EM LA and saline and Group C (PLlLIG) placebo cream and IOJo lignocaine.
Assessments using 100 mm visual analog pain scales (VAPS) were made of pain due to skin infiltration and pain from midline insertion of a 16-gauge Tuohy needle into the supraspinous ligament. The attending nurse also rated the patient's response on a scale: O=no patient response; 1 = facial grimace; 2 = verbal exclamation or physical withdrawal.
Based on a prior evaluation of lignocaine infiltration in which 40OJo of women recorded a pain score less than 15 during skin infiltration, it was calculated that a sample size of 27 per group would be required to double this percentage after EMLA application (a =0.05, f3=0.2). Analyses were performed using the F test, Kruskal-Wallis Chi squared and Fisher's Exact test as appropriate, and correlations using Pearson and Spearman tests.
RESULTS
Seven women were excluded, six due to incomplete collection of data and one due to inadequate EMLA application time, leaving 76 analysed data sets.
The groups were comparable for age, weight, parity and EMLA application time (Table 1) . There were significantly higher pain scores for skin infiltration in Group C (PLlLIG) and for epidural needle insertion in Group B (EM/SAL). The percentage of women with a pain score less than 15 during skin infiltration was significantly greater in the groups receiving EMLA (71OJo versus 28OJo, P< 0.001 Fisher's Exact test). The percentage of women with a pain score less than 15 during epidural needle insertion was significantly greater in the groups receiving lignocaine (54OJo versus 31OJo, P<0.05 Fisher's Exact test) ( Table 2) . Correlation between nurse assessment and patient pain score showed a concordance of 53070 for skin infiltration and 71OJo for epidural needle insertion.
DISCUSSION
This study, conducted in women having epidural anaesthesia without prior sedation, found that early application of EMLA cream combined with skin infiltration using IOJo lignocaine optimized patient comfort for epidural insertion.
Our results confirm that transient pain of moderate severity occurs on skin infiltration with lignocaine, and that this can be significantly reduced by the use of EMLA. Other techniques for minimizing such pain include alkalinization or warming of lignocaine or the use of procaine as the local anaesthetic. Alkalinization of lignocaine and the use of 1070 procaine have been shown to significantly decrease pain 5 ,6; however, studies confict as to the value of warming solutions to body temperature 7 ,s.
EMLA provided a 5 mm depth of analgesia on the forearm, as determined with an 18 gauge needle'. Analgesia to 16 mm was observed with insertion of a 25 gauge needle into the upper arm, suggesting that analgesia provided by EMLA extends into subcutaneous tissue 2 • Our study supports these findings, however, despite the good dermal analgesia obtained for infiltration with smaller gauge needles, EMLA alone was inadequate for insertion of a 16 gauge Tuohy needle.
This study did not address the optimal application time for EMLA prior to epidural needle insertion. The recommended time prior to venepuncture is 60 minutes and for split skin grafts 60-90 minutes 9 ,1O Application to the back results in a rapid onset of analgesia (within 30 minutes) which wanes immediately after removal of cream anaesthetist felt lignocaine infiltration to be superior4. We also found EMLA alone to be inadequate despite application for 90 minutes. However, it has been suggested that the greater dermal thickness of the back might be able to absorb and redistribute a larger volume of EM LA, such that 2.5g is insufficient'o. Thus further studies using larger doses over various application times may be warranted.
The poor level of concordance between nursing assessment and patient pain scores confirmed that observer ratings are not a reliable indicator of pain experienced. The nurse rating was more likely to underestimate patients' pain. Ralston et al made a similar observation, finding that their midwives overestimated and anaesthetists underestimated patients' pain4.
EMLA product information indicates that, although its safety in pregnancy has not been established, both lignocaine and prilocaine have been used in a large number of pregnant women without an increase in the incidence of malformations or observation of harmful fetal effects. This is the first randomized, double-blind study to investigate the efficacy of EMLA prior to epidural insertion. However, it should be noted that observer blinding may have been compromised to some extent since EMLA more frequently caused skin changes than placebo cream. Nevertheless, it would appear that the combination of early topical EMLA and subsequent local infiltration with 1070 lignocaine results in minimal patient discomfort and significantly reduces pain scores for epidural insertion, compared to either EM LA or lignocaine infiltration alone. This may confer a benefit not only for the patient but also for the anaesthetist, in that the procedure may be easier to perform".
We recommend the combination of EMLA and infiltration with lignocaine for planned epidural analgesia or anaesthesia for the unsedated obstetric patient, and believe it warrants evaluation in other patient groups. 
